对非典型细菌拓糖酶抑制剂的结构和机制见解
Paul D Toth1, Steven C Ratigan1, Joshua W Powell1
1Department of Chemistry and Biochemistry, College of Arts and Sciences, Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Division of Pharmaceutics and Pharmacology, College of Pharmacy, Department of Biological Chemistry and Pharmacology, College of Medicine, The Ohio State University, Columbus, Ohio 43210, United States of America.
ACS medicinal chemistry letters
|April 18, 2025
概括
新型细菌拓酶抑制剂 (NBTI) 显示出对抗MRSA的希望. 一些NBTI导致单链和双链DNA断裂,为对抗致命的病原体提供了一种新的策略.
科学领域:
- 微生物学 微生物学
- 药用化学 医学化学
- 结构生物学 结构生物学
背景情况:
- 新型细菌拓酶抑制剂 (NBTI) 是一种有前途的新型抗菌药物.
- 这些抑制剂向重要的细菌酶,如DNA转化酶和4号拓酶,对于对抗MRSA等病原体至关重要.
- 已知一组胺基NBTI可诱导单链和双链DNA断裂,使其与大多数NBTI有所区别.
研究的目的:
- 为两个胺基NBTI (148和185) 阐明一种不寻常的结合模式的结构基础.
- 为了合成和描述新型异构三醇NBTI.
- 研究由这些新化合物诱导的差异性DNA裂变机制.
主要方法:
- 使用X射线晶体学来确定胺基NBTI148和185的结构.
- 进行了两种同质三醇NBTI (342和276) 的合成.
- 采用对接和分子动力学模拟来分析DNA裂变机制.
主要成果:
- X射线晶体结构揭示了NBTI148和185的异常结合模式,涉及GyrA D83和R122.
- 三醇NBTI 342只诱导单链DNA断裂,而三醇NBTI 276则诱导单链和双链DNA断裂.
- 计算机模拟提供了对不同DNA裂变活动背后的结构因素的洞察.
结论:
- 这项研究揭示了胺基NBTI与细菌拓聚合酶的独特结合相互作用.
- 异构三醇NBTI的开发具有不同的DNA裂变配置文件,扩大了NBTI类.
- 了解这些结构和机制上的差异是设计下一代抗菌剂的关键.
相关概念视频
02:02DNA Topoisomerases
30.5K
Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
30.5K
01:29Cytoskeletal Proteins in Bacteria
3.2K
Bacterial cells were initially considered simple, randomly organized structures lacking a cytoskeleton. However, the discovery of cytoskeleton homologs in bacteria led to the change of this opinion. Bacterial cytoskeletal filaments regulate the cell shape, cell polarity, cell division, and partitioning of plasmids during cell division. It was later discovered that bacterial cytoskeletal proteins, mainly actin and tubulin homologs, are diverse compared to their eukaryotic counterparts. On the...
3.2K
01:19Allosteric Proteins-ATCase
5.6K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.6K
01:26Targets for Drug Action: Overview
5.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
5.9K
00:46Feedback Inhibition
53.4K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
53.4K
01:27Combined Effects of Drugs: Synergism
3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.6K